Applied Health Economics and Health Policy

Papers
(The TQCC of Applied Health Economics and Health Policy is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Cost-Effectiveness and Value of Information Analyses of Caplacizumab for the Treatment of Thrombotic Thrombocytopenic Purpura in Brazil158
Cost-Effectiveness of a Universal School-Based Mental Health Prevention Program: An Economic Modeling Study in a Limited Income Context86
Population Norms for SF-6Dv2 and EQ-5D-5L in China41
Which Factors are Holding up the Integration of the Environmental Impact of Health Technologies in Health Technology Assessment? Insights from a Multi-Stakeholder Interview Study39
Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach38
Improving Consumer Engagement in Health Technology Assessment and Decision Making: Lessons from ‘Values in Science’35
Cost-Effectiveness Analysis of Evolocumab or Inclisiran in Combination with Statins Versus Statin Monotherapy Among Patients with ASCVD in China30
Cost-Effectiveness of Perinatal Depression Screening: A Scoping Review29
Assessing the Direct Impact of Death on Discrete Choice Experiment Utilities29
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework24
Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?24
Therapy, Pills and Unmet Needs for Financial Reasons: Socioeconomic Inequalities and Inequities in Access to Mental Health Care in Spain 2014–202024
Psychometric Evaluation of the PedsQL GCS and CHU9D in Australian Children and Adolescents with Common Chronic Health Conditions23
Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines23
Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand23
Selection and Prioritization of Medical Devices for HTA Evaluation: A Systematic Review of Existing Approaches23
The Economics of Antibiotic Resistance: A Systematic Review and Meta-analysis Based on Global Research22
A Guideline-Implementation Intervention to Improve the Management of Low Back Pain in Primary Care: A Difference-in-Difference-in-Differences Analysis20
Local Level Economic Evaluation: What is it? What is its Value? Is it Sustainable?19
Exploratory Approach to Incorporating Carbon Footprint in Health Technology Assessment (HTA) Modelling: Cost-Effectiveness Analysis of Health Interventions in the United Kingdom19
Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis18
How is Value Defined in Molecular Testing in Cancer? A Scoping Review16
Financing Comprehensive Immunization Services in Lao PDR: A Fiscal Space Analysis From a Public Policy Perspective16
The Economic Cost of Rising Non-communicable Diseases in India: A Systematic Literature Review of Methods and Estimates15
Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies15
10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?15
A Cost–Utility Analysis of Surgical Site Infection Prevention: Broadening the Scope15
Acknowledgement to Reviewers13
Correction: Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?13
A Systematic Review of the World’s Largest Government Sponsored Health Insurance Scheme for 500 Million Beneficiaries in India: Pradhan Mantri Jan Arogya Yojana13
Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach12
Including Pharmaceuticals in Bundled Payments12
How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts12
Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients12
Contextual Factors that Influence Antibiotic Prescribing: A Discrete Choice Experiment of GP Registrars12
Scope Issue in Contingent Valuation Studies of the COVID-19 Vaccine: The Case of China12
Social Costs of Smoking in the Czech Republic12
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes12
Measures of Performance and Clinical Superiority Thresholds for ‘Test-and-treat’ Predictive Biomarkers11
Guiding Health Resource Allocation: Using Population Net Health Benefit to Align Disease Burden with Cost Effectiveness for Informed Decision Making11
Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India11
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy11
Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon11
Correction to: Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L11
Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi10
Cost-Effectiveness and Budget Impact Analysis of Implementing a 'Soft Opt-Out' System for Kidney Donation in Australia10
A Systematic Review of Cost-Effectiveness Analyses of Colorectal Cancer Screening in Europe: Have Studies Included Optimal Screening Intensities?10
Is Economic Evaluation and Care Commissioning Focused on Achieving the Same Outcomes? Resource-Allocation Considerations and Challenges Using England as a Case Study10
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations10
Herd Immunity Effects in Cost-Effectiveness Analyses among Low- and Middle-Income Countries9
Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–20409
Young People’s Preferences for Web-Based Mental Health Interventions for Managing Anxiety and Depression: A Discrete Choice Experiment9
Trump’s Drug Pricing Order and the Domestic Economic Trade-Off9
Cost-Effectiveness of Anti-retroviral Adherence Interventions for People Living with HIV: A Systematic Review of Decision Analytical Models9
Cost-effectiveness Analysis of the Dental RECUR Pragmatic Randomized Controlled Trial: Evaluating a Goal-oriented Talking Intervention to Prevent Reoccurrence of Dental Caries in Children8
Machine Learning-Assisted Health Economics and Policy Reviews: A Comparative Assessment8
Sedaconda ACD-S for Sedation with Volatile Anaesthetics in Intensive Care: A NICE Medical Technologies Guidance8
Measurement of Catastrophic Health Expenditure in India: A Systematic Review and Meta-Analysis8
Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting8
Forecasting the Incremental Value to Society Created by a Class of New Prescription Drugs: A Proposed Methodology and Its Application to Treating Chronic Hepatitis C in India8
Productivity Loss and Indirect Costs for Patients Newly Diagnosed with Early- versus Late-Stage Cancer in the USA: A Large-Scale Observational Research Study8
Mechanisms Considering Public Investment in Pricing and Reimbursement Decisions of Medicines and Other Health Technologies: A Scoping Review8
Information Asymmetry in Hospitals: Evidence of the Lack of Cost Awareness in Clinicians8
The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework8
Analysing the Efficiency of Health Systems: A Systematic Review of the Literature8
Estimating a Drug’s Price After Loss of Exclusivity as a Function of Its Cost of Goods Sold8
Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland8
Comparing Preferences for Disease Profiles: A Discrete Choice Experiment from a US Societal Perspective8
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges8
Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older8
The Health Economics of Genomic Technologies: A Growing Evidence Base on Value8
Using Genomic Heterogeneity to Inform Therapeutic Decisions for Metastatic Colorectal Cancer: An Application of the Value of Heterogeneity Framework7
Discrete Event Simulation in R using the ‘Simmer’ Package for Health Economic Modelling: A Tutorial and Illustration in Colon Cancer7
A Systematic Review of Economic Evaluations on Interventions Targeting Insomnia or Hypersomnia7
A Head-On Comparison of EQ-VT- and Crosswalk-Based EQ-5D-5L Value Sets7
The Limitations and Potentials of Evaluating Economic Aspects of Community-Based Health Promotion: A Critical Review7
Headroom Analysis for Early Economic Evaluation: A Systematic Review7
EQ-5D-5L Population Norms for Italy7
A Systematic Review of Health Economic Evaluations and Budget Impact Analyses to Inform Healthcare Decision-Making in Central America6
Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment6
Discrete Choice Experiments in Health State Valuation: A Systematic Review of Progress and New Trends6
Exploring Consumer Preferences for Cannabis Vaping Products to Support Public Health Policy: A Discrete Choice Experiment6
Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?6
Health Reform in Aotearoa New Zealand: Insights on Health Equity Challenges One Year On6
The Impact of Value-Based Payment Models for Networks of Care and Transmural Care: A Systematic Literature Review6
Estimated Carbon Savings from Changing Surgical Trends in Primary Elective Total Hip Arthroplasty in England: A Retrospective Observational Study6
Use of Decision-Analytic Modelling to Assess the Cost-Effectiveness of Diagnostic Imaging of the Spine, Shoulder, and Knee: A Scoping Review6
Modelled Distributional Cost-Effectiveness Analysis of Childhood Obesity Interventions: A Demonstration6
Preferences for Digital Mental Health Services in Urban China: A Discrete Choice Experiment6
0.035604000091553